ArticleInternational journal of clinical oncology2025

Phase Ib study of the oral PI3Kδ inhibitor linperlisib in patients with advanced solid tumors.

Jin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.